Skip to main content
Joseph Sodroski, MD, Internal Medicine, Boston, MA, Dana-Farber Cancer Institute

JosephGerardSodroskiMD

Internal Medicine • Boston, MA

Professor at Dana-Farber Cancer Institute / Harvard Medical School

Join to view full profile

Dr. Sodroski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sodroski's full profile

Already have an account?

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1980

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Journal Articles

  • Conformational Differences Between Functional Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Trimers and Stabilized Soluble Trimers  
    Joseph Sodroski, MD, mBio
  • SOSIP Changes Affect Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformation and CD4 Engagement  
    Joseph Sodroski, MD, mBio
  • Contribution of the gp120 V3 Loop to Envelope Glycoprotein Trimer Stability in Primate Immunodeficiency Viruses  
    Joseph Sodroski, MD, ScienceDirect

Press Mentions

  • Flossie Wong-Staal Helped Unlock Mysteries of HIV
    Flossie Wong-Staal Helped Unlock Mysteries of HIVJuly 24th, 2020
  • TRIM5α Cytoplasmic Bodies Are Highly Dynamic Structures
    TRIM5α Cytoplasmic Bodies Are Highly Dynamic StructuresMarch 28th, 2007

Grant Support

  • Broad-Range Inhibitors Of Human Immunodeficiency Virus EntryNational Institute On Drug Abuse2012
  • Single-Particle Reconstruction Of HIV-1 Envelope Glycoprotein TrimersNational Institute Of Allergy And Infectious Diseases2011–2012
  • Antiretroviral Activity Of Trim5alphaNational Institute Of Allergy And Infectious Diseases2005–2012
  • HIV-1 Envelope GlycoproteinsNational Institute Of Allergy And Infectious Diseases1996–2012
  • Structure-Based Antagonism Of HIV-1 Envelope Function In Cell EntryNational Institute Of General Medical Sciences2007–2011
  • Structure Of The Retroviral Restriction Factor, Trim5alphaNational Institute Of Allergy And Infectious Diseases2007–2008
  • Molecular Studies Of HIV1 Neutralizing AntibodiesNational Institute Of Allergy And Infectious Diseases1998–2007
  • Structural Analysis Of HIV1 Envelope GlycoproteinsNational Institute Of Allergy And Infectious Diseases1997–2006
  • Molecular Interaction Between HIV1 Gp120-Cd4 ComplexesNational Institute Of Allergy And Infectious Diseases1997–2006
  • A Study To Determine The Replicative/Pathologic Ability Of Chimeric SIV/HIVNational Center For Research Resources2004
  • HIV-1 Oligomeric Envelope-ProteoliposomesNational Institute Of Allergy And Infectious Diseases2002–2004
  • Topological Analysis Of HIV-1 Envelope GlycoproteinsNational Institute Of Allergy And Infectious Diseases2000–2004
  • Replication And Pathogenicity Of HIV/SIV ChimeraeNational Institute Of Allergy And Infectious Diseases1999–2004
  • Dfci-Bidmc-Ch Center For AIDS ResearchNational Institute Of Allergy And Infectious Diseases1999–2003
  • Adaption Of HIV Vectors To NonprimatesNational Heart, Lung, And Blood Institute2000–2002
  • Core--Developmental FacilityNational Institute Of Allergy And Infectious Diseases1999–2002
  • Core--Biohazard Containment FacilityNational Institute Of Allergy And Infectious Diseases1999–2002
  • Core--Virology And Biology FacilityNational Institute Of General Medical Sciences1997–2002
  • Vaccine Vectors Based On HIV-1National Institute Of Allergy And Infectious Diseases1999–2000
  • Developmental CoreNational Institute Of Allergy And Infectious Diseases1996–1998
  • Core--Biohazard ContainmentNational Institute Of Allergy And Infectious Diseases1996–1998
  • AIDS ResearchNational Institute Of Allergy And Infectious Diseases1994–1998
  • Replication And Pathogenicity Of HIV/SIV ChimerasNational Institute Of Allergy And Infectious Diseases1993–1998
  • Molecular Studies Of HIV 1 Neutralizing AntibodiesNational Institute Of Allergy And Infectious Diseases1994–1997
  • HIV 1 Envelope GlycoproteinsNational Institute Of Allergy And Infectious Diseases1996
  • Model To Evaluate Requirements For HIV-1 ProphylaxisNational Institute Of Allergy And Infectious Diseases1994–1996
  • HIV-1 Envelope GlycoproteinsNational Institute Of Allergy And Infectious Diseases1993–1995
  • Screening And Drug Design Of HIV-1 TherapeuticsNational Institute Of Allergy And Infectious Diseases1993–1994
  • Pathogenic Provirus Of SivmacNational Institute Of Allergy And Infectious Diseases1993–1994
  • Molecular Characterization Of Monoclonal AntibodiesNational Institute Of Allergy And Infectious Diseases1991–1993
  • Development Of HIV As A Vector SystemNational Institute Of Allergy And Infectious Diseases1989–1993
  • Role Of The HIV-1 Envelope Glycoproteins In ReplicationNational Institute Of Allergy And Infectious Diseases1990–1992
  • Role Of Glycosylation In HIV Envelope ImmunogenicityNational Institute Of Allergy And Infectious Diseases1989–1991
  • Role Of The HTLV-III Envelope Glycoprotein In VirusNational Institute Of Allergy And Infectious Diseases1987–1989
  • Role Of HTLV LOR Region In Transcriptional RegulationNational Cancer Institute1985–1987
  • Expression And Potential Function Of BLV LTR RegionNational Cancer Institute1985–1987

Hospital Affiliations

Dr. Joseph Sodroski, Dr. Joseph Sodroski, MD, Dr. J Sodroski, Dr. Joseph Gerard Sodroski